ResMed
414 hedge funds and large institutions have $7.57B invested in ResMed in 2017 Q4 according to their latest regulatory filings, with 78 funds opening new positions, 151 increasing their positions, 115 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
15% more funds holding
Funds holding: 361 → 414 (+53)
11% more capital invested
Capital invested by funds: $6.84B → $7.57B (+$723M)
0.48% more ownership
Funds ownership: 62.48% → 62.96% (+0.48%)
Holders
414
Holding in Top 10
6
Calls
$10.3M
Puts
$5.8M
Top Buyers
| 1 | +$133M | |
| 2 | +$70.9M | |
| 3 | +$20M | |
| 4 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$19.4M |
| 5 |
JPMorgan Chase & Co
New York
|
+$15M |
Top Sellers
| 1 | -$165M | |
| 2 | -$45.3M | |
| 3 | -$25.8M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$19.7M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
-$15.4M |